CURE AL™
A Community United for Real Elimination of HCV in Alabama
Tuesday, November 17, 2026
6:45 PM-7:45 PM CT
Birmingham, AL
UAB Medicine - Heersink School of Medicine
Department of Psychiatry and Behavioral Neurobiology
Birmingham, Alabama
Target Audience
This educational initiative is intended for addiction services providers: counselors, MDs, NPs, PAs, nurses, pharmacists, case managers, peer educators, medical assistants, as well as primary care clinicians and other frontline providers.
Educational Objectives
- Discuss national and local hepatitis C (HCV) epidemiology and infection risks among PWUD populations
- Define HCV antibody positivity, HCV RNA positivity, and reflex testing
- Provide education and counseling on curative HCV treatment and preventive harm-reduction strategies to PWUD
- Deliver guideline-directed universal and risk-based screening, as well as a direct link to low-barrier HCV treatment in cases of HCV positivity
Program Description
The CURE AL initiative brings a focused, community-driven approach to HCV elimination in Jefferson County, Alabama, with a strategic emphasis on screening and linkage to care for people who use drugs (PWUD). This live, interactive educational session is designed specifically for substance use disorder service professionals, who play a critical role in reaching high-risk individuals. Participants will explore national and local HCV epidemiology, transmission risks among PWUD, and key diagnostic concepts, including HCV antibody positivity, HCV RNA positivity, and confirmatory testing. Additionally, the program will emphasize the practical application of guideline-directed universal and risk-based screening and counseling on curative treatment and harm-reduction strategies and establish direct, low-barrier pathways to HCV care, with the goal of ultimately strengthening local care networks and accelerating progress toward HCV elimination in Jefferson County.
Physician Accreditation Statement
Physician Credit Designation
Nursing Contact Hours Designation
Addiction Prevention Coalition designates this continuing education activity for 1.0 contact hour including 0.0 pharmacotherapeutic contact hour.
Social Worker Credit
Instructions to Receive Credit
Fee Information
Disclosure of Relevant Financial Relationships
Integritas Communications and APC adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies
Sarah Palecek Hewitt, DNP, FNP-C, CEN has nothing to disclose
The planners and managers at Integritas Communications and Addiction Prevention Coalition have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Mara Simpson prior to the live event at msimpson@integritasgrp.com.
Contact Information
For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com.
For information about the accreditation (Social worker credit) of this program, please contact APC at ashley@apcbham.org.
Register Now
This educational activity is jointly provided by Integritas Communications and Addiction Prevention Coalition (APC).
This activity is supported by an educational grant from AbbVie Inc.
15
2026
Non-CME Corporate Forum sponsored by Blueprint Medicines and Cogent Biosciences.
Systemic Mastocytosis in the Spotlight: Focusing on Diagnosis and Management of Nonadvanced SM
| Time: | 6:45 AM-7:45 AM MT |
| Venue: | Sheraton Phoenix Downtown, Phoenix Ballroom Salon A (3rd Level) |
| Location: | Phoenix, AZ |
| Faculty: | Matthew P. Giannetti, MD ; Jeremy C. McMurray, MD; Cecelia Y. Arana Yi, MD |
15
2026
Non-CME Corporate Forum sponsored by Blueprint Medicines and Cogent Biosciences.
Systemic Mastocytosis in the Spotlight: Focusing on Diagnosis and Management of Nonadvanced SM
| Time: | 6:45 AM-7:45 AM MT |
| Venue: | Live Stream |
| Location: | Live Stream |
| Faculty: | Matthew P. Giannetti, MD ; Jeremy C. McMurray, MD; Cecelia Y. Arana Yi, MD |
